small molecule

CLOBETASOL PROPIONATE

CLOBETASOL PROPIONATE

Loss of exclusivityloss of exclusivity
CompanySAPTALIS PHARMACEUTICALS LLC

Drug detail

Brand nameCLOBETASOL PROPIONATE
Active ingredientCLOBETASOL PROPIONATE
Strength0.05%
Dosage formSOLUTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalOctober 2019
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CLOBETASOL PROPIONATE patent cliff — loss of exclusivity — | CliffBio